Reproductive TechniquesNCT04261660
Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer
An observational study of Reproductive Techniques, run by Carmel Medical Center.
Trial summary
Assessing the relationship between the VEGF levels in blood and the IVF protocol Read more about this study
- Who is it for?
- Ages 18 to 40 years, women only
- Conditions the study is for
- Reproductive Techniques
- How many people
- 90 participants
- Where
- No sites listed yet
- Study dates
- 1 Mar 2020to 1 Apr 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- Adult
Study population: Female patients undergoing ovum pickup and embryo transfer as part of assited reproductive technologies
Who may be able to join
- Patients undergoing IVF -
Who cannot join
- Women with any malignancy
- Patients request to be withdrawn
Trial locations and contacts
No sites are listed yet.
About this study
Assessing the relationship between the VEGF levels in blood and the IVF protocol
Read the detailed description
The investigators are assessing the VEGF levels in the blood in IVF patients undergoing different protocols
- Conditions
- Reproductive Techniques
- Being tested
- NO intervention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
NO interventionOther
NO INTERVENTION
| Study group | Role | What they receive |
|---|---|---|
| fresh | NO INTERVENTION Receives: Other: NO intervention | |
| Frozen embro transfer natural | NO INTERVENTION Receives: Other: NO intervention | |
| Frozen embro transfer hormonal | NO INTERVENTION Receives: Other: NO intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
vascular endothelial growth factor LEVELS
levels of vascular endothelial growth factor in blood
Measured: 5 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2020
- Study start1 Mar 2020 (estimated)
- Primary completion1 Mar 2021 (estimated)
- Study completion1 Apr 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Reproductive TechniquesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Carmel Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ido Feferkorn, Carmel Medical Center
- Investigators
- Ido Feferkorn, MD, Principal investigator, Carmel Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04261660
- Sponsor's protocol ID
- CMC-19-0161-CTIL
- Status last verified
- Feb 2020
- First submitted
- 6 Feb 2020
- Last updated
- 10 Feb 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer
- ClinicalTrials.gov ID
- NCT04261660
- Acronym / sponsor ID
- CMC-19-0161-CTIL
- Conditions
- Reproductive Techniques
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Carmel Medical CenterUniversity, hospital or other
- Study start
- 1 Mar 2020 (estimated)
- Primary completion
- 1 Mar 2021 (estimated)
- Study completion
- 1 Apr 2021 (estimated)
- First posted
- 10 Feb 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assessing the relationship between the VEGF levels in blood and the IVF protocol
Detailed description
The investigators are assessing the VEGF levels in the blood in IVF patients undergoing different protocols
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| fresh | – | Other: NO interventionNO INTERVENTION |
| Frozen embro transfer natural | – | Other: NO interventionNO INTERVENTION |
| Frozen embro transfer hormonal | – | Other: NO interventionNO INTERVENTION |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- Female patients undergoing ovum pickup and embryo transfer as part of assited reproductive technologies
Key inclusion criteria (1 listed)
- Patients undergoing IVF -
Key exclusion criteria (2 listed)
- Women with any malignancy
- Patients request to be withdrawn
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| NO interventionNO INTERVENTION | Other | Frozen embro transfer hormonal, Frozen embro transfer natural, fresh |
Primary outcome
vascular endothelial growth factor LEVELS
Time frame: 5 days
levels of vascular endothelial growth factor in blood
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2020.
- Individual participant dataSharing planned: No
Related trials for Reproductive Techniques
Not yet recruiting
Impact of Gender-Transformative Interventions on Contraceptive Use and Reproductive Autonomy in Somalia
Contraceptive Behavior, Social Norms
Recruiting
Impact of Self-Care Family Planning Services on Health and Development in South Sudan (Family Planning Impact Lab)
Contraceptive Behavior, Self Administration
Enrolling by invitation
A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions
Contraceptive Usage, Contraceptive Behavior
Not yet recruitingObservational study
Exploring Reproductive Decision-Making Among Women With Multiple Sclerosis
Multiple Sclerosis
RecruitingObservational study
Efficacy and Safety of a New Sperm Capacitation Method
Reproductive Issues, Male Infertility
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ido Feferkorn, MD principal investigator
Carmel Medical Center
Questions about this trial
What is this clinical trial studying?
An observational study of Reproductive Techniques, run by Carmel Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 10 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact ido Fefekorn, MD (+972-54-3537401, idofe@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
vascular endothelial growth factor LEVELS (time frame: 5 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2020.